Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytology

ThyroSeq v2 claims high positive (PPV) and negative (NPV) predictive values in a wide range of pretest risks of malignancy in indeterminate thyroid nodules (ITNs) (categories B-III and B-IV of the Bethesda system). We evaluated ThyroSeq v2 performance in a cohort of patients with ITNs seen at our Ac...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Endocr Relat Cancer
Autors principals: Valderrabano, Pablo, Khazai, Laila, Leon, Marino E, Thompson, Zachary J, Ma, Zhenjun, Chung, Christine H, Hallanger-Johnson, Julie E, Otto, Kristen J, Rogers, Kara D, Centeno, Barbara A, McIver, Bryan
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7771306/
https://ncbi.nlm.nih.gov/pubmed/28104680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-16-0512
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars